M. Cohen

发表

Beta1 and beta2 receptor mechanisms in rat jugular veins: differences between norepinephrine and isoproterenol-induced relaxation.

M. Cohen, K. Wiley, K. S. Wiley, 1978, Life sciences.

Serotonin in migraine: theories, animal models and emerging therapies.

L. Phebus, M. Cohen, M L Cohen, 1998, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

Low-affinity M(2) receptor binding state mediates mouse atrial bradycardia: comparative effects of carbamylcholine and the M(1) receptor agonists sabcomeline and xanomeline.

M. Cohen, P. Stengel, 2001, The Journal of pharmacology and experimental therapeutics.

M(2) and M(4) receptor knockout mice: muscarinic receptor function in cardiac and smooth muscle in vitro.

J. Gomeza, J. Wess, M. Cohen, 2000, The Journal of pharmacology and experimental therapeutics.

Aryl propanolamines: comparison of activity at human β3 receptors, rat β3 receptors and rat atrial receptors mediating tachycardia

A. Kriauciunas, M. Cohen, Marlene L. Cohen, 1999, British journal of pharmacology.

The incidence and natural history of pericardial effusion after cardiac surgery--an echocardiographic study.

I. Kronzon, F. Spencer, M. Cohen, 1984, Circulation.

Fluid preload before spinal anaesthesia in Caesarean section: the effect on neonatal acid–base status

M. Cohen, D. Sherman, M. Bahar, 2006, European Journal of Anaesthesiology.

5-Hydroxytryptamine(1F) receptors do not participate in vasoconstriction: lack of vasoconstriction to LY344864, a selective serotonin(1F) receptor agonist in rabbit saphenous vein.

M. Cohen, K. Schenck, Marlene L. Cohen, 1999, The Journal of pharmacology and experimental therapeutics.

Contractile responses to sumatriptan and ergotamine in the rabbit saphenous vein: effect of selective 5‐HT1F receptor agonists and PGF2α

M. Cohen, Marlene L. Cohen, K. Schenck, 2000, British journal of pharmacology.

Serotonin and Smooth Muscle

M. Cohen, A. L. Killam, A. Killam, 1994 .

Accidental venous and dural puncture during epidural analgesia in obese parturients (BMI > 40 kg/m2): three different body positions during insertion.

M. Cohen, M. Bahar, Z. Haitov, 2010, Journal of clinical anesthesia.

Lack of a difference between ketanserin and ritanserin in central vs. peripheral serotonin receptor antagonism.

R. Fuller, H. Snoddy, M. Cohen, 1989, Life sciences.

In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides.

M. Cohen, R. Kauffman, K. Schenck, 1987, The Journal of pharmacology and experimental therapeutics.

Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421.

M. Cohen, K. Kurz, 1982, The Journal of pharmacology and experimental therapeutics.

Diastolic atrial compression: a sensitive echocardiographic sign of cardiac tamponade.

I. Kronzon, M. Cohen, H. Winer, 1983, Journal of the American College of Cardiology.

Hypotensive properties of the protein kinase inhibitor, staurosporine, in normotensive and spontaneously hypertensive rats.

J. Turk, M. Cohen, R. Secrest, 1991, Clinical and experimental hypertension. Part A, Theory and practice.

Serotonin-induced contraction in canine coronary artery and saphenous vein: role of a 5-HT1D-like receptor.

M. Cohen, M. Baez, K. Schenck, 1994, Life sciences.

Degradation of exogenous enkephalin in the guinea-pig ileum: relative importance of aminopeptidase, enkephalinase and angiotensin converting enzyme activity.

M. Cohen, K. Wiley, L. E. Geary, 1982, The Journal of pharmacology and experimental therapeutics.

Relationship between phospholipase D activation and endothelial vasomotor dysfunction in rabbit aorta.

D. Cox, M. Cohen, Marlene L. Cohen, 1997, The Journal of pharmacology and experimental therapeutics.

Reversible doxorubicin-induced congestive heart failure.

M. Cohen, I. Kronzon, A. Lebowitz, 1982, Archives of internal medicine.

Effects of prolonged isoproterenol infusion on cardiac and vascular responses to adrenoceptor agonists.

M. Cohen, K. S. Schenck, V. Wyss, 1986, The Journal of pharmacology and experimental therapeutics.

Somatostatin inhibits adrenergic and cholinergic neurotransmission in smooth muscle.

M. Cohen, K. Wiley, I. Slater, 1978, Life sciences.

Serum Amyloid P in Alzheimer's Disease

S. Younkin, R. Kalaria, T. Golde, 1991, Annals of the New York Academy of Sciences.

Cardiac tamponade by loculated pericardial hematoma: limitations of M-mode echocardiography.

I. Kronzon, M. Cohen, H. Winer, 1983, Journal of the American College of Cardiology.

Captopril and MK-421: stability on storage, distribution to the central nervous system, and onset of activity.

M. Cohen, K. Kurz, 1983, Federation proceedings.

Alterations in left ventricular mass and performance in patients treated effectively for thyrotoxicosis. A comparative echocardiographic study.

J. V. Nixon, R. Anderson, M. Cohen, 1979, The American journal of medicine.

On the cerebral accumulation of ketamine and the relationship between metabolism of the drug and its pharmacological effects.

M. Cohen, A. Trevor, 1974, The Journal of pharmacology and experimental therapeutics.

Selective enhancement of 5-hydroxytryptamine-induced contraction of porcine coronary artery by oxidized low-density lipoprotein.

D. Cox, M. Cohen, 1996, The Journal of pharmacology and experimental therapeutics.

Adverse effect of hydralazine in patients with primary pulmonary hypertension.

I. Kronzon, M. Cohen, H. Winer, 1982, JAMA.

Migraine Therapy

M. Cohen, LA Phebus, KW Johnson, 1997, Cephalalgia : an international journal of headache.

Vasoactive intestinal polypeptide: increased tone, enhancement of acetylcholine release, and stimulation of adenylate cyclase in intestinal smooth muscle.

M. Cohen, A. Landry, 1980, Life sciences.

Adverse hemodynamic effects of phentolamine in primary pulmonary hypertension.

M. Cohen, I. Kronzon, 1981, Annals of internal medicine.

Humoral factors in massive pulmonary embolism: an experimental study.

M. Cohen, D. Thomas, V. Gurewich, 1968, American heart journal.

Effects of oxidized low-density lipoprotein on vascular contraction and relaxation: clinical and pharmacological implications in atherosclerosis.

D. Cox, M. Cohen, 1996, Pharmacological reviews.

Investigations into the physiological role of muscarinic M2 and M4 muscarinic and M4 receptor subtypes using receptor knockout mice.

F. Bymaster, C. Felder, P. Carter, 2001, Life sciences.

Editorials: Updating sphygmomanometry.

M. Cohen, H. Alexander, L. Steinfeld, 1974, The American journal of cardiology.

Antagonism of serotonin3 (5-HT3) receptors within the blood-brain barrier prevents cisplatin-induced emesis in dogs.

D. Wong, J. Gidda, D. Robertson, 1995, The Journal of pharmacology and experimental therapeutics.

Sumatriptan and 5-benzyloxytryptamine: contractility of two 5-HT1D receptor ligands in canine saphenous veins.

D. Robertson, M. Cohen, K. Schenck, 1992, European journal of pharmacology.

Role of 5-HT2 receptors in serotonin-induced contractions of nonvascular smooth muscle.

M. Cohen, K. Schenck, W. Colbert, 1985, The Journal of pharmacology and experimental therapeutics.

Endothelin: differential effects in vascular and nonvascular smooth muscle.

M. Cohen, R. Secrest, Roberta J. Secrest, 1989, Life sciences.

Differences between the effects of dopamine and apomorphine on rat aortic strips.

M. Cohen, B. Berkowitz, 1975, European journal of pharmacology.

Pharmacological activity of the isomers of LY53857, potent and selective 5-HT2 receptor antagonists.

R. Fuller, M. Cohen, N. Mason, 1985, The Journal of pharmacology and experimental therapeutics.

Noninvasive diagnosis of left coronary arteriovenous fistula communicating with the right ventricle.

I. Kronzon, M. Cohen, H. Winer, 1982, The American journal of cardiology.

Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine.

R. Fuller, M. Cohen, 1983, Life sciences.

Advanced glycation modification of Rosenthal fibers in patients with Alexander disease

M. Smith, R. Castellani, V. Monnier, 1997, Neuroscience Letters.

Decreased vascular relaxation in hypertension.

M. Cohen, B. Berkowitz, 1976, The Journal of pharmacology and experimental therapeutics.

Treatment of prosthetic tricuspid valve thrombosis with low-dose tissue plasminogen activator.

A. Jaffe, P. Eisenberg, B. Barzilai, 1990, American heart journal.

Evidence for a captopril-sensitive angiotensin converting enzyme in the hindquarter vasculature of SHR and WKY.

S. Mueller, M. Cohen, 1985, Artery.

Effect of acute oral administration of captopril and MK-421 on vascular angiotensin converting enzyme activity in the spontaneously hypertensive rat.

M. Cohen, K. Wiley, K. Kurz, 1983, Life sciences.

Characterization of rat platelet serotonin receptors with tryptamine agonists and the antagonists: ketanserin and SCH 23390.

M. Cohen, A. L. Killam, A. Killam, 1991, Thrombosis research.

Contribution of echocardiography to the understanding of the pathophysiology of cardiac tamponade.

I. Kronzon, M. Cohen, H. Winer, 1983, Journal of the American College of Cardiology.

Substances used for local and general anaesthesia in major surgery suppress proliferative responsiveness of normal rat peripheral blood mononuclear cells in culture.

M. Cohen, M. Bahar, J. Weissgarten, 2000, European journal of anaesthesiology.

Effects of prolonged ethinyl estradiol treatment on calcium channel binding and in vivo calcium-mediated hemodynamic responses in ovariectomized rats.

C. Vlahos, H. Bryant, M. Cohen, 1997, The Journal of pharmacology and experimental therapeutics.

Effect of labetalol and YM-09538 on neuronal uptake of (3H)norepinephrine in the rat vas deferens.

M. Cohen, L. M. Hynes, 1983, Clinical and experimental hypertension. Part A, Theory and practice.

Enkephalin degradation in the guinea-pig ileum: effect of aminopeptidase inhibitors, puromycin and bestatin.

M. Cohen, K. Wiley, L. E. Geary, 1983, Journal of Pharmacology and Experimental Therapeutics.

Regulation of TNF-alpha by 1alpha,25-dihydroxyvitamin D3 in human macrophages from CAPD patients.

A. Douvdevani, S. Shany, C. Chaimovitz, 2001, Kidney international.

5HT2 receptors in the rat portal vein: desensitization following cumulative serotonin addition.

M. Cohen, N. Mason, H. Lemberger, 1984, Life sciences.

Aging and vasodilation to atrial peptides.

M. Cohen, J. Emmick, 1986, Clinical and experimental hypertension. Part A, Theory and practice.

Antagonism of a peripheral vascular but not an apparently central serotonergic response by xylamidine and BW 501C67.

R. Fuller, M. Cohen, N. Mason, 1986, European journal of pharmacology.

Mechanism of action of ketanserin in hypertension

S. Ball, T. Hedner, J. Symoens, 1986 .

Evidence for 5-HT2 receptors mediating contraction in vascular smooth muscle.

R. Fuller, M. Cohen, K. Wiley, 1981, The Journal of pharmacology and experimental therapeutics.

Echocardiographic findings after tricuspid valvectomy.

I. Kronzon, M. Cohen, J. Nobile, 1985, Chest.

Inhibition of serotonin-amplified human platelet aggregation by ketanserin, ritanserin, and the ergoline 5HT2 receptor antagonists-LY53857, sergolexole, and LY237733.

J. Mann, E. Nimchinsky, M. Cohen, 1990, Life Science.

Serotonin-induced pulmonary responses in the perfused guinea pig lung: evidence for 5HT2 receptor-mediated pulmonary vascular and airway smooth muscle constriction.

M. Cohen, J. Fleisch, W. Selig, 1988, Pulmonary pharmacology.

Effect of LY287045, a thrombin/trypsin inhibitor, on thrombin and trypsin-induced aortic contraction and relaxation.

G. F. Smith, M. Cohen, A. Bhattacharya, 2001, The Journal of pharmacology and experimental therapeutics.

Vascular contraction and relaxation to thrombin and trypsin: thrombomodulin preferentially attenuates thrombin-induced contraction.

M. Cohen, A. Bhattacharya, 2000, The Journal of pharmacology and experimental therapeutics.

A high density in vitro extracellular electrode array: description and implementation.

P. Corr, J. Saffitz, R. Hoyt, 1989, American Journal of Physiology.

An investigation of the possible neurotoxic effects of intrathecal midazolam combined with fentanyl in the rat.

M. Cohen, M. Bahar, M. Chanimov, 1998, European journal of anaesthesiology.

Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives.

D. Thompson, M. Cohen, W. Bloomquist, 1998, Journal of medicinal chemistry.

Indazoles as indole bioisosteres: synthesis and evaluation of the tropanyl ester and amide of indazole-3-carboxylate as antagonists at the serotonin 5HT3 receptor.

J. Deeter, N. D. Jones, M. Cohen, 1987, Journal of medicinal chemistry.

Synthesis and biochemical evaluation of tritium-labeled 1-methyl-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-1H-indazole-3-carboxa mide, a useful radioligand for 5HT3 receptors.

D. Wong, D. Robertson, L. R. Reid, 1990, Journal of medicinal chemistry.

Potent, selective tetrahydro-beta-carboline antagonists of the serotonin 2B (5HT2B) contractile receptor in the rat stomach fundus.

D. Nelson, J. Audia, M. Cohen, 1996, Journal of medicinal chemistry.

mCPP but not TFMPP is an antagonist at cardiac 5HT3 receptors.

D. Wong, D. Robertson, M. Cohen, 1992, Life sciences.

N-[3-(2-Dimethylaminoethyl)-2-methyl-1H- indol-5-yl]-4-fluorobenzamide: a potent, selective, and orally active 5-HT(1F) receptor agonist potentially useful for migraine therapy.

J. Zgombick, D. Nelson, J. Audia, 2001, Journal of medicinal chemistry.

Zatosetron, a potent, selective, and long-acting 5HT3 receptor antagonist: synthesis and structure-activity relationships.

R L Simon, D. Robertson, M. Cohen, 1992, Journal of medicinal chemistry.

Serotonin Receptor Activation of Phosphoinositide Turnover in Uterine, Fundal, Vascular, and Tracheal Smooth Muscle

M. Cohen, L. Wittenauer, 1987, Journal of cardiovascular pharmacology.

D. Cox, M. Cohen, 1994, European journal of pharmacology.

6-Methylergoline-8-carboxylic acid esters as serotonin antagonists: N1-substituent effects on 5HT2 receptor affinity.

M. Cohen, G. Marzoni, W. L. Garbrecht, 1987, Journal of medicinal chemistry.

Distribution in the Brain and Metabolism of Ketamine in the Rat after Intravenous Administration

M. Cohen, W. L. Way, A. Trevor, 1973, Anesthesiology.

M. Cohen, B. Berkowitz, 1974, The Journal of pharmacology and experimental therapeutics.

Use of the mouse vas deferens to determine mu, delta, and kappa receptor affinities of opioid antagonists.

C. Mitch, D. Zimmerman, M. Cohen, 1994, Receptor.

In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist properties.

J. Boot, D. Nelson, M. Cohen, 2001, European journal of pharmacology.

LY277359 maleate: a potent and selective 5-HT3 receptor antagonist without gastroprokinetic activity.

J. Gidda, M. Cohen, W. Bloomquist, 1990, The Journal of pharmacology and experimental therapeutics.

Effects of Pinacidil on Serotonin‐Induced Contractions and Cyclic Nucleotide Levels in Isolated Rat Aortae: Comparison with Nitroglycerin, Minoxidil, and Hydralazine

M. Cohen, R. Kauffman, K. Schenck, 1986, Journal of cardiovascular pharmacology.

Vascular contraction: effect of age and extracellular calcium.

M. Cohen, B A Berkowitz, M L Cohen, 1976, Blood vessels.

Vascular responsiveness to norepinephrine, serotonin, and potassium chloride in veins from spontaneously hypertensive and age-matched Wistar Kyoto rats.

M. Cohen, K. Wiley, 1979, Clinical and experimental hypertension.

CCK-8, CCK-4 and gastrin-induced contractions in guinea pig ileum: evidence for differential release of acetylcholine and substance P by CCK-A and CCK-B receptors.

M. Cohen, V. Lucaites, N. Mason, 1991, The Journal of pharmacology and experimental therapeutics.

Specific enhancement of norepinephrine-induced contraction in rat veins after beta adrenergic antagonists.

M. Cohen, K. Wiley, 1977, The Journal of pharmacology and experimental therapeutics.

Vascular adenylate cyclase: role of age and guanine nucleotide activation.

M. Cohen, A. Blume, B. Berkowitz, 1977, Blood vessels.

Rat jugular vein relaxes to norepinephrine, phenylephrine and histamine.

M. Cohen, K. Wiley, K. S. Wiley, 1978, The Journal of pharmacology and experimental therapeutics.

Amesergide and structurally related nor-D-ergolines: 5HT2 receptor interactions in the rat.

M. Martinelli, M. Cohen, W. Bloomquist, 1993, Journal of medicinal chemistry.

Contractile responses in bladder body, bladder neck and prostate from rat, guinea pig and cat.

M. Cohen, K. Drey, 1989, The Journal of pharmacology and experimental therapeutics.

The beta amyloid protein precursor: mRNAs, membrane-associated forms, and soluble derivatives.

R. Tanzi, J. Gusella, P. Whitehouse, 1989, Progress in clinical and biological research.

Potent antagonism of 5-HT(3) and 5-HT(6) receptors by olanzapine.

F. Bymaster, J. Kennedy, M. Cohen, 2001, European journal of pharmacology.

LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat.

R. Fuller, M. Cohen, K. Kurz, 1983, The Journal of pharmacology and experimental therapeutics.

Evidence that blood pressure reduction by serotonin antagonists is related to alpha receptor blockade in spontaneously hypertensive rats.

R. Fuller, M. Cohen, K. Kurz, 1983, Hypertension.

5-Hydroxytryptamine(1A) receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein.

M. Cohen, K. Schenck, S. H. Hemrick-Luecke, 1999, The Journal of pharmacology and experimental therapeutics.

Effect of meta-chlorophenylpiperazine (mCPP), a central serotonin agonist and vascular serotonin receptor antagonist, on blood pressure in SHR.

R. Fuller, M. Cohen, K. Kurz, 1987, Clinical and experimental hypertension. Part A, Theory and practice.

In vitro receptor specificity of the 5HT1A selective phenylpiperazine, LY165163.

M. Cohen, K. Schenck, N. Mason, 1986, Life sciences.

Further evidence that vascular serotonin receptors are of the 5HT2 type.

R. Fuller, M. Cohen, K. Wiley, 1983, Biochemical pharmacology.

Norepinephrine, monoamine oxidase, and acetylcholinesterase in the rat jugular vein compared with other blood vessels.

R. Fuller, M. Cohen, A. Landry, 1979, Canadian journal of physiology and pharmacology.

Bradykinin-induced contractions of canine prostate and bladder: effect of angiotensin-converting enzyme inhibition.

B. Neubauer, M. Cohen, C. Steidle, 1990, The Journal of urology.

Comparison of arteries with longitudinal and circular venous muscle from the rat.

M. Cohen, K. Wiley, 1977, The American journal of physiology.

Neuronal uptake inhibitors, nisoxetine and fluoxetine on rat vascular contractions.

M. Cohen, K. Wiley, 1977, European journal of pharmacology.

Cyclic AMP in the rat jugular vein: relationship to vascular relaxation.

M. Cohen, A. Landry, 1979, European journal of pharmacology.

Pharmacology of Smooth Muscle

J. Papp, M. Cohen, L. Szekeres, 2011, Handbook of Experimental Pharmacology.

Dextran 40 (Rheomacrodex) or Polygeline (Haemaccel) as an epidural patch for post dural puncture headache: a neurotoxicity study in a rat model of Dextran 40 and Polygeline injected intrathecally

J. Sandbank, M. Cohen, M. Bahar, 2006, European journal of anaesthesiology.

Arthrokinetic reflex of the knee.

L. Cohen, M. Cohen, 1956, American Journal of Physiology.

Spinal anaesthesia induced by intrathecal magnesium sulphate.

M. Cohen, M. Bahar, M. Chanimov, 1996, Anaesthesia.

Comparison of the serotonin receptors that mediate smooth muscle contraction in canine and porcine coronary artery.

M. Cohen, D. Cushing, 1992, The Journal of pharmacology and experimental therapeutics.

LY215840, a potent 5-hydroxytryptamine (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2 receptors and delays occlusion in a rabbit model of thrombosis.

D. Robertson, M. Cohen, W. Bloomquist, 1992, The Journal of pharmacology and experimental therapeutics.

Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.

D. Nelson, J. Audia, M. Cohen, 1993, Molecular pharmacology.

Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.

J. Gidda, M. Cohen, W. Bloomquist, 1989, The Journal of pharmacology and experimental therapeutics.

Sterile, caseous mitral anular abscess.

I. Kronzon, M. Cohen, H. Winer, 1983, Journal of the American College of Cardiology.

Use of two-dimensional echocardiography during transseptal cardiac catheterization.

I Kronzon, E Glassman, I. Kronzon, 1984, Journal of the American College of Cardiology.

Left ventricular outflow obstruction: a complication of mitral valvuloplasty.

I. Kronzon, M. Cohen, S. Colvin, 1984, Journal of the American College of Cardiology.

Permanent transvenous catheter pacing. Six-year experience.

R. Cowley, M. Cohen, L. Scherlis, 1973, The Journal of thoracic and cardiovascular surgery.

Zatosetron, a 5-HT3 receptor antagonist in a multicenter trial for acute migraine

M. Cohen, A. Chappell, G. D. Botzum, 1994, Neuropharmacology.

Amyloid protein precursor messenger RNAs: differential expression in Alzheimer's disease.

R. Tanzi, J. Gusella, S. Younkin, 1988, Science.

In situ hybridization of nucleus basalis neurons shows increased beta-amyloid mRNA in Alzheimer disease.

S. Younkin, L. Younkin, T. Golde, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Superior vena caval blood flow velocities in adults: a Doppler echocardiographic study.

I Kronzon, I. Kronzon, G. Lighty, 1986, Journal of applied physiology.

Assisted circulation. II. The effect of heart rate on synchronized arterial counterpulsation.

M. Cohen, D. Harken, A. Lefemine, 1962, American heart journal.

Lysophosphatidylcholine stimulates phospholipase D in human coronary endothelial cells: role of PKC.

D. Cox, M. Cohen, 1996, The American journal of physiology.

Differential regulation of intestinal amino-oligopeptidase gene expression in neonatal and adult rats.

M. Cohen, G. M. Gray, J. S. Zhu, 1991, The American journal of physiology.

Contractile serotonin-2A receptor signal transduction in guinea pig trachea: importance of protein kinase C and extracellular and intracellular calcium but not phosphoinositide hydrolysis.

D. Cox, D. Schoepp, M. Cohen, 1994, The Journal of pharmacology and experimental therapeutics.

Selective desensitization of 5-hydroxytryptamine 2A receptor mediated contraction in guinea pig trachea.

M. Cohen, S. Watts, K. Schenck, 1994, Canadian journal of physiology and pharmacology.

Zn2+ metabolism affects apoptosis rate and proliferative responsiveness of PBMC from patients on chronic hemodialysis

M. Cohen, M. Rapoport, J. Weissgarten, 2002 .

Is the "atypical" beta-receptor in the rat stomach fundus the rat beta 3 receptor?

J. Granneman, M. Cohen, A. Palkowitz, 1995, Journal of Pharmacology and Experimental Therapeutics.

Alterations of intercellular junctions induced by hypoxia in canine myocardium.

J E Saffitz, P B Corr, P. Corr, 1990, The American journal of physiology.

Neuronal binucleation in Alzheimer disease hippocampus

Yufei Wang, M. Smith, R. Castellani, 2008, Neuropathology and applied neurobiology.

Spinal anaesthesia with gamma hydroxybutyrate. A study in a rat model.

M. Cohen, M. Bahar, Y. Grinshpon, 1999, European journal of anaesthesiology.

In vitro comparison of the pre- and postsynaptic alpha adrenergic receptor blocking properties of prazosin and tiodazosin (BL5111).

M. Cohen, K. Wiley, A. Landry, 1980, Clinical and experimental hypertension.

Intestinal lactase: maturational excess expression of mRNA over enzyme protein.

M. Cohen, G. M. Gray, J. S. Zhu, 1993, The American journal of physiology.

Assisted circulation. III. The effect of synchronized arterial counterpulsation on myocardial oxygen consumption and coronary flow.

M. Cohen, D. Harken, A. Lefemine, 1962, American heart journal.

Relationship between receptors mediating serotonin (5-HT) contractions in the canine basilar artery to 5-HT1, 5-HT2 and rat stomach fundus 5-HT receptors.

M. Cohen, W. Colbert, 1986, The Journal of pharmacology and experimental therapeutics.

Contractile serotonergic receptor in rat stomach fundus.

M. Cohen, L. A. Fludzinski, 1987, The Journal of pharmacology and experimental therapeutics.

Effect of nitrendipine, diltiazem, trifluoperazine and pimozide on serotonin2 (5-HT2) receptor activation in the rat uterus and jugular vein.

M. Cohen, K. Schenck, N. Mason, 1986, The Journal of pharmacology and experimental therapeutics.

In vitro relaxation of arteries and veins by prazosin: alpha-adrenergic blockade with no direct vasodilation.

M. Cohen, K. Wiley, I. H. Slater, 1979, Blood & Vessel.

Atriopeptin II: differential sensitivity of arteries and veins from the rat.

M. Cohen, K. Schenck, 1985, European journal of pharmacology.

Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.

M. Cohen, D. Cushing, 1993, Journal of Pharmacology and Experimental Therapeutics.

Serotonin-induced relaxation in canine coronary artery smooth muscle.

M. Cohen, D. Cushing, 1992, The Journal of pharmacology and experimental therapeutics.

Relationship between serotonin and tryptamine receptors in the rat stomach fundus.

M. Cohen, L. Wittenauer, 1985, The Journal of pharmacology and experimental therapeutics.

Alpha 2-agonist activity of the dopamine DA2-agonist LY171555.

M. Cohen, C. Shaar, W. Colbert, 1984, Journal of cardiovascular pharmacology.

Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus.

D. Nelson, M. Cohen, M. Baez, 1992, Molecular pharmacology.

Pharmacological and molecular evidence that the contractile response to serotonin in rat stomach fundus is not mediated by activation of the 5-hydroxytryptamine1C receptor.

M. Cohen, M. Baez, L. Yu, 1990, Molecular pharmacology.

Antagonist dissociation constants and relative agonist efficacies for compounds interacting with beta-1 and beta-2 adrenergic receptors in the rat jugular vein.

R. Ruffolo, M. Cohen, K. Wiley, 1980, The Journal of pharmacology and experimental therapeutics.

Further evidence that the serotonin receptor in the rat stomach fundus is not 5HT1A or 5HT1B.

M. Cohen, L. Wittenauer, 1986, Life sciences.

Relationship between 5-HT2A receptor mRNA density and contractility in trachea and aorta from guinea pig and rat.

L. Mercurio, M. Cohen, M. Baez, 1994, Life Science.

LY215840, a high-affinity 5-HT7 receptor ligand, blocks serotonin-induced relaxation in canine coronary artery.

J. Zgombick, D. Nelson, M. Cohen, 1996, The Journal of pharmacology and experimental therapeutics.

Effect of acute and subchronic subcutaneous urocortin on blood pressure and food consumption in ob/ob mice.

S. Iyengar, M. Cohen, W. Bloomquist, 2000, General pharmacology.

Time-dependent improvement in guinea pig tracheal contractility: modification by cyclooxygenase inhibitors.

M. Cohen, S. Watts, 1993, The Journal of pharmacology and experimental therapeutics.

Further evidence that the guinea pig tracheal contractile serotonergic receptor is a 5-hydroxytryptamine2 receptor: use of 5-methyltryptamine and dipropyl-5-carboxamidotryptamine.

M. Cohen, S. Watts, 1993, The Journal of pharmacology and experimental therapeutics.

Characterization of the contractile serotonergic receptor in guinea pig trachea with agonists and antagonists.

M. Cohen, S. Watts, 1992, The Journal of pharmacology and experimental therapeutics.

Comparison of contractions to serotonin, carbamylcholine and prostaglandin F2 alpha in rat stomach fundus.

D. Schoepp, M. Cohen, R. Secrest, 1989, The Journal of pharmacology and experimental therapeutics.

Effect of LY53857, a selective 5HT2 receptor antagonist, on 5HT-induced increases in cutaneous vascular permeability in rats.

M. Cohen, K. Schenck, 1989, Life sciences.

Experimental cardiac tamponade: correlation of pressure, flow velocity, and echocardiographic changes.

M. Cohen, 1990, Journal of applied physiology.

Ionophore (A23187)-induced efflux of [3H]norepinephrine and endogenous norepinephrine in the rat vas deferens.

K. Perry, R. Fuller, M. Cohen, 1981, European journal of pharmacology.

Enantiomers of [R,S]-thiorphan: dissociation of analgesia from enkephalinase A inhibition.

D. Evans, M. Cohen, R. Frederickson, 1985, Life sciences.

Serotonin-induced pulmonary responses are mediated by the 5-HT2 receptor in the mouse.

J. Drazen, T. Martin, M. Cohen, 1994, The Journal of pharmacology and experimental therapeutics.

Tissue angiotensin converting enzyme inhibition as an index of the disposition of enalapril (MK-421) and metabolite MK-422.

M. Cohen, K. Schenck, K. Kurz, 1983, The Journal of pharmacology and experimental therapeutics.

Canine, but not rat bladder contracts to serotonin via activation of 5HT2 receptors.

M. Cohen, 1990, The Journal of urology.

DOI and alpha-methylserotonin: comparative vascular and nonvascular smooth muscle effects and central 5-hydroxytryptamine2 receptor affinities.

D. Robertson, D. Nelson, M. Cohen, 1993, Journal of Pharmacology and Experimental Therapeutics.

Differences in ligand binding profiles between cloned rabbit and human 5-HT1D alpha and 5-HT1D beta receptors: ketanserin and methiothepin distinguish rabbit 5-HT1D receptor subtypes.

T. Branchek, J. Zgombick, R. Weinshank, 1996, Naunyn-Schmiedeberg's archives of pharmacology.

Synthetic and fermentation-derived angiotensin-converting enzyme inhibitors.

M. Cohen, 1985, Annual review of pharmacology and toxicology.

Candida albicans-infected transvenous pacemaker wire: detection by two-dimensional echocardiography.

M. Cohen, A. Gargiulo, I. Kronzon, 1986, American Heart Journal.

(8 beta)-6-methylergoline amide derivatives as serotonin antagonists: N1-substituent effects on vascular 5HT2 receptor activity.

M. Cohen, J. Misner, G. Marzoni, 1990, Journal of medicinal chemistry.

5-Hydroxytryptamine2 receptor antagonist activity of the acid metabolite (1-isopropyl dihydrolysergic acid) of the ergoline ester, sergolexole (LY281067).

R. Fuller, M. Cohen, C. Parli, 1989, The Journal of pharmacology and experimental therapeutics.

Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067.

R. Fuller, R. E. Toomey, M. Cohen, 1988, The Journal of pharmacology and experimental therapeutics.

Zn metabolism affects apoptosis rate and proliferative responsiveness of PBMC from patients on chronic hemodialysis.

M. Cohen, J. Weissgarten, D. Modai, 2002, Metabolism: Clinical and Experimental.

Intrathecal anaesthesia alters intracellular Ca2+/Mg2+ homeostasis in the spinal cord neurones of experimental rats

M. Cohen, M. Bahar, J. Weissgarten, 2001, European journal of anaesthesiology.

2,3-Dialkyl(dimethylamino)indoles: interaction with 5HT1, 5HT2, and rat stomach fundal serotonin receptors.

M. Cohen, K. Schenck, L. Wittenauer, 1986, Journal of medicinal chemistry.

Substances used for local and general anaesthesia in major surgery suppress proliferative responsiveness of normal rat peripheral blood mononuclear cells in culture.

M. Cohen, M. Bahar, J. Weissgarten, 2000, European journal of anaesthesiology.

Small Sample Behavior of Some Robust Linear Estimators of Location

Joseph L. Gastwirth, J. Gastwirth, M. Cohen, 1970 .